← Back to catalog
On request
Onset
2–3 days
Duration
3–4 months
Daewoong · code N100
Nabota 100U
Glabellar lines, crow’s feet, forehead (Jeuveau)
Price on request
Add to your request for a current quote
Specifications
- Manufacturer
- Daewoong
- Origin
- South Korea
- Units
- 100U
- Type
- Botulinum toxin type A
- Form
- Powder for solution
- Storage
- 2–8°C
- Code
- N100
For licensed professionals only. Prescription-grade product supplied to specialists; confirm the current price before ordering.
About the product
Overview
Nabota is produced by Daewoong Pharmaceutical using the proprietary HiPure technology platform. Internationally, Nabota is marketed as Jeuveau in the United States (FDA-approved 2019) and Nuceiva in Europe — making it one of the few Korean-origin toxins with major Western regulatory approval.
HiPure aims to deliver a highly pure toxin with reduced accessory protein content. Nabota is favoured by aesthetic clinics prioritising a premium-tier Korean option with international clinical credibility.
What it helps with
Indications
- Glabellar frown lines (FDA-cleared indication in US as Jeuveau)
- Crow's feet
- Forehead horizontal wrinkles
- Premium-tier aesthetic protocols
Why choose it
Key properties
- ✓HiPure manufacturing technology
- ✓Same molecule as Jeuveau (US) / Nuceiva (EU)
- ✓FDA-approved formulation (as Jeuveau)
- ✓Onset from 2–3 days
- ✓Duration typically 3–4 months
Important
Prescription-grade product supplied exclusively to licensed cosmetologists, medical aesthetic practitioners and clinics. Not for sale to end consumers. Clinical judgement, informed consent and appropriate protocol selection remain the responsibility of the treating professional. Prices are indicative — final terms confirmed on the current price list.